Health and Healthcare
Are Gilead Earnings Enough for Investors?
Published:
Last Updated:
Perhaps the number that most investors were watching in this report was the worldwide hepatitis C vaccine sales of $4.798 billion versus analysts’ estimates of $4.5 billion.
Product sales in the U.S. totaled $5.6 billion compared to $4.2 billion last year. In Europe, product sales rang in at $1.7 billion compared to $1.4 billion for the same period in 2014. Sales in other international locations increased to $1.0 billion compared to $327 million primarily as a result of the launch of HCV products in Japan.
On the books, Gilead had $25.1 billion in cash, cash equivalents and marketable securities compared to $14.7 billion as of June 30, 2015. This increase was primarily driven by the issuance of senior unsecured notes in September 2015 for a total aggregate principal amount of $10.0 billion. During the third quarter, the company generated $4.1 billion in operating cash flow, utilized $3.1 billion to repurchase 28 million shares and paid a cash dividend of $0.43 per share, totaling $627 million.
Separately, the company announced that the board of directors declared a cash dividend of $0.43 per share of common stock for the fourth quarter. The dividend will be payable on December 30, to stockholders of record at the close of business on December 16.
Shares of Gilead closed Tuesday up 2.1% at $110.96, with a consensus analyst price target of $124.25 and a 52-week trading range of $85.95 to $123.37. Following the release of the earnings report, shares were initially down 1.5% at $10.25 in the after-hours trading session.
ALSO READ: The 10 Most Profitable Companies in the World
The thought of burdening your family with a financial disaster is most Americans’ nightmare. However, recent studies show that over 100 million Americans still don’t have proper life insurance in the event they pass away.
Life insurance can bring peace of mind – ensuring your loved ones are safeguarded against unforeseen expenses and debts. With premiums often lower than expected and a variety of plans tailored to different life stages and health conditions, securing a policy is more accessible than ever.
A quick, no-obligation quote can provide valuable insight into what’s available and what might best suit your family’s needs. Life insurance is a simple step you can take today to help secure peace of mind for your loved ones tomorrow.
Click here to learn how to get a quote in just a few minutes.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.